Next-generation sequencing: A transformative tool for vaccinology

Expert Review of Vaccines

Volumn 8, Issue 8, 2009, Pages 963-967

  Dhiman, Neelam ^a   Smith, David I ^a   Poland, Gregory A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MICRORNA; NUCLEOTIDE; OLIGONUCLEOTIDE; RIBOSOME RNA; SINGLE STRANDED DNA; SMALL NUCLEAR RNA; TRANSFER RNA; UNTRANSLATED RNA; VACCINE; VIRUS VACCINE;

ANTIBODY RESPONSE; CLINICAL RESEARCH; DNA FRAGMENTATION; DNA TEMPLATE; EDITORIAL; FEASIBILITY STUDY; GENE AMPLIFICATION; GENETIC VARIABILITY; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HERITABILITY; HIGH THROUGHPUT SCREENING; HUMAN; HYBRIDIZATION; IMMUNE RESPONSE; METAGENOMICS; NEXT GENERATION SEQUENCING; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTOMICS;

HUMANS; SEQUENCE ANALYSIS, DNA; VACCINES;

EID: 68049144603     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/erv.09.67     Document Type: Editorial

References (32)

1. Voelkerding KV, Dames SA, Durtschi JD. Next-generation sequencing: from basic research to diagnostics. Clin. Chem. 55(4), 641-658 (2009).
2. Morozova O, Marra MA. Applications of next-generation sequencing technologies in functional genomics. Genomics 92, 255-264 (2008).
3. Harismendy O, Ng PC, Strausberg RL et al. Evaluation of next generation sequencing platforms for population targeted sequencing studies. Genome Biol. 10, R32 (2009).
4. Lo YM, Chiu RW. Next-generation sequencing of plasma/serum DNA: an emerging research and molecular diagnostic tool. Clin. Chem. 55, 607-608 (2009).
5. Ansorge WJ. Next-generation DNA sequencing techniques. Nat. Biotechnol. 25, 195-203 (2009).
6. Sultan M, Schulz MH, Richard H et al. A global view of gene activity and alternative splicing by deep sequencing of the human transcriptome. Science 321, 956-960 (2008).
7. Gorringe KL, Campbell IG. Large-scale genomic ana lysis of ovarian carcinomas. Mol. Oncol. 3, 157-164 (2009).
8. Cloonan N, Forrest AR, Kolle G et al. Stem cell transcriptome profiling via massive-scale mRNA sequencing. Nat. Methods 5, 613-619 (2008).
9. Rozera G, Abbate I, Bruselles A et al. Massively parallel pyrosequencing highlights minority variants in the HIV-1 env quasispecies deriving from lymphomonocyte sub-populations. Retrovirology 6, 15 (2009).
10. Clark AG. Genome sequences from extinct relatives. Cell 134, 388-389 (2008).
11. Wegner KM. Massive parallel MHC genotyping: titanium that shines. Mol. Ecol. 18, 1818-1820 (2009).
12. Nagalakshmi U, Wang Z, Waern K et al. The transcriptional landscape of the yeast genome defined by RNA sequencing. Science 320, 1344-1349 (2008).
13. Wang Z, Gerstein M, Snyder M. RNA-seq: a revolutionary tool for transcriptomics. Nat. Rev. Genet. 10, 57-63 (2009).
14. Huber JA, Mark Welch DB, Morrison HG et al. Microbial population structures in the deep marine biosphere. Science 318, 97-100 (2007).
15. Urich T, Lanzen A, Qi J, Huson DH, Schleper C, Schuster SC. Simultaneous assessment of soil microbial community structure and function through ana lysis of the meta-transcriptome. PLoS ONE 3, e2527 (2008).
16. Keijser BJ, Zaura E, Huse SM et al. Pyrosequencing ana lysis of the oral microflora of healthy adults. J. Dent. Res. 87, 1016-1020 (2008).
17. Johnson DS, Mortazavi A, Myers RM, Wold B. Genome-wide mapping of in vivo protein-DNA interactions. Science 316, 1497-1502 (2007).
18. Ball MP, Li JB, Gao Y et al. Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells. Nat. Biotechnol. 27, 361-368 (2009).
19. Wang C, Mitsuya Y, Gharizadeh B, Ronaghi M, Shafer RW. Characterization of mutation spectra with ultra-deep pyrosequencing: application to HIV-1 drug resistance. Genome Res. 17, 1195-1201 (2007).
20. Guffanti A, Iacono M, Pelucchi P et al. A transcriptional sketch of a primary human breast cancer by 454 deep sequencing. BMC Genomics 10, 163 (2009).
21. Tang F, Barbacioru C, Wang Y et al. mRNA-seq whole-transcriptome ana lysis of a single cell. Nat. Methods 6, 377-382 (2009).
22. Jacobson RM, Ovsyannikova IG, Targonski PV, Poland GA. Studies of twins in vaccinology. Vaccine 25, 3160-3164 (2007).
23. Poland GA, Ovsyannikova IG, Jacobson RM, Smith DI. Heterogeneity in vaccine immune response: the role of immunogenetics and the emerging field of vaccinomics. Clin. Pharmacol. Ther. 82, 653-664 (2007).
24. Berezikov E, Cuppen E, Plasterk RH. Approaches to microRNA discovery. Nat. Genet. 38(Suppl.), S2-S7 (2006).
25. Redon R, Ishikawa S, Fitch KR et al. Global variation in copy number in the human genome. Nature 444(7118), 444-454 (2006).
26. Xie C, Tammi MT. CNV-seq, a new method to detect copy number variation using high-throughput sequencing. BMC Bioinformatics 10, 80 (2009).
27. Minarovits J. Microbe-induced epigenetic alterations in host cells: the coming era of patho-epigenetics of microbial infections. A review. Acta Microbiol. Immunol. Hung. 56, 1-19 (2009).
28. Poland G. Personalized vaccines: the emerging field of vaccinomics. Exp. Opin. Biol. Ther. 8, 1659-1667 (2008).
29. Reif DM, McKinney BA, Motsinger AA et al. Genetic basis for adverse events after smallpox vaccination. J. Infect. Dis. 198, 1-7 (2008).
30. Poland GA, Ovsyannikova IG, Jacobson RM. Vaccine immunogenetics: bedside to bench to population. Vaccine 26, 6183-6188 (2008).
31. 1000 genomes. A deep catalog of human genetic variation www.1000genomes.org
32. National Human Genome Research Institute. NHGRI seeks DNA sequencing technologies fit for routine laboratory and medical use. New grants drive development of rapid, cost-effective sequencing technologies www.genome.gov/27527585